Last update 05 Jul 2025

CG-102-12

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms-
Target
GPC3
Action
inhibitors
Mechanism
GPC3 inhibitors(Glypican-3 inhibitors)
Therapeutic Areas
NeoplasmsDigestive System Disorders
Active Indication
Advanced Hepatocellular CarcinomaGPC3 Positive Hepatocellular Carcinoma
Inactive Indication-
Originator Organization
Cells & Genes Biotech (Shanghai) Co.,Ltd
Active Organization
Cells & Genes Biotech (Shanghai) Co.,Ltd
Inactive Organization-
License Organization-
Drug Highest PhaseClinical
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with CG-102-12
NCT07039201
/ Not yet recruitingNot ApplicableIIT
An Exploratory Clinical Study on the Safety and Efficacy of Autologous Chimeric Antigen Receptor T Cells Targeting Glypican-3 (CG-102-12C) in the Treament of Advanced Hepatocellular Carcinoma
ChiCTR2400083608
/ SuspendedEarly Phase 1IIT
IIT trial of chimeric antigen receptor T cells targeting Glypican-3 in treatment of advance hepatocellular carcinoma
100 Clinical Results associated with CG-102-12
Login to view more data
100 Translational Medicine associated with CG-102-12
Login to view more data
100 Patents (Medical) associated with CG-102-12
Login to view more data
100 Deals associated with CG-102-12
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatocellular CarcinomaPhase 1-
Cells & Genes Biotech (Shanghai) Co.,Ltd
-
Advanced Hepatocellular CarcinomaClinical
China
Cells & Genes Biotech (Shanghai) Co.,Ltd
20 Jun 2025
GPC3 Positive Hepatocellular CarcinomaClinical
China
Cells & Genes Biotech (Shanghai) Co.,Ltd
20 Jun 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free